Investing in the Future of Healthcare Access
Join us in democratizing remote patient monitoring and capturing the $11B Medicare RPM market
The Opportunity
Massive market, proven model, untapped potential
Market Size
- • $11B Medicare RPM market
- • 54M Medicare beneficiaries
- • 133M Americans with chronic disease
- • 90% unserved by current solutions
Revenue Model
- • B2B: $91-167 per patient/month
- • Medicare CPT codes 99453-99458
- • B2C: $29-49 monthly subscriptions
- • Device sales & partnerships
Competitive Edge
- • Cellular-first (no internet needed)
- • Dual-market approach (B2B + B2C)
- • Automated billing compliance
- • Digital equity focus
The Problem
- × Healthcare Access Gaps: 47M Americans lack broadband, can't use internet-dependent RPM
- × Provider Revenue Loss: Providers miss $2,000+ per patient annually in Medicare reimbursements
- × Compliance Burden: Manual documentation causes 30-40% claim denials
- × Patient Outcomes: Poor medication adherence costs $290B annually in preventable hospitalizations
Our Solution
- ✓ Cellular-First Design: Works without internet via cellular-enabled medical devices
- ✓ Automated Reimbursement: Captures all CPT codes 99453-99458, maximizing provider revenue
- ✓ Compliance Automation: Auto-generates documentation, prevents claim denials
- ✓ Medication Adherence: Smart reminders and tracking reduce hospitalizations
Current Status
Building the foundation for transformative impact
12-Month Roadmap
Q1 2026 - Funding & Launch
- • Secure seed funding
- • Launch pilot study recruitment
- • Complete device integration
Q2 2026 - Pilot Execution
- • Enroll first 50 patients
- • Begin data collection
- • Launch B2C platform beta
Q3 2026 - Early Traction
- • First provider partnerships
- • 100+ active patients
- • Preliminary results analysis
Q4 2026 - Scale Preparation
- • 500+ patients across platforms
- • Publish pilot study results
- • Prepare Series A fundraise
Financial Projections
Conservative estimates, aggressive potential
| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| B2B Patients | 500 | 5,000 | 25,000 | 100,000 |
| B2C Subscribers | 200 | 2,000 | 10,000 | 50,000 |
| Annual Revenue | $750K | $7.5M | $37M | $150M |
| Gross Margin | 45% | 60% | 70% | 75% |
| EBITDA | ($500K) | $750K | $8M | $40M |
Use of Funds
Strategic allocation for maximum growth
Platform enhancements, device integration, AI features
Provider outreach, B2C acquisition, partnerships
Expanded pilot studies, peer-reviewed publications
HIPAA, HITRUST certification, legal, HR
Runway extension, unforeseen expenses
Founder
Building the future of accessible healthcare
Alex Struz
Healthcare technology innovator building cellular-first RPM solutions to eliminate digital health barriers. Passionate about bridging the healthcare access gap for underserved populations.
📧 Contact AlexSeeking Advisors: We're actively looking for experienced advisors in clinical medicine, healthcare reimbursement, and healthtech scaling. Interested in joining our advisory board? Get in touch.
Seed Round Opportunity
Join us at the ground floor
This Round Enables:
- ✓ Launch 50-patient pilot study with clinical data collection
- ✓ Complete cellular device integration with Transtek partnership
- ✓ Hire 2 key team members (sales & clinical operations)
- ✓ Launch B2C platform and acquire first 200 subscribers
- ✓ Secure first 3-5 provider partnerships
- ✓ Build foundation for Series A fundraise in 2027
Early Investor Benefits: Ground-floor valuation, direct founder access, strategic input on product roadmap, and first look at Series A participation.
Let's Talk
Ready to join us in transforming healthcare access for millions?
Get in Touch
Direct Contact:
alexstruz@ev-bo.com24-48 hour reply
Virtual or in-person
Accept investments anytime